TCI GENE Business Summary

TCI GENE (6879.TWO) operates as a vertically integrated precision medicine and wellness company, utilizing a "Predict, Prevent, Personal Treatment" business model to monetize genetic data through diagnostic services and customized health products. The company generates revenue across three primary segments: high-throughput genetic testing (including wellness, obesity, and cardiovascular risk assessments), regenerative medicine (adipose-derived stem cell and natural killer cell therapies), and personalized functional foods. By leveraging its proprietary healthy gene database specifically optimized for Asian Chinese populations, TCI GENE differentiates itself from clinical-only diagnostics firms by bridging the gap between genomic insights and the direct manufacturing of patented, bio-designed supplements and skincare. In the competitive landscape of Taiwan's precision medicine market, TCI GENE competes directly with ACT Genomics (Prenetics), GGA Corp (GeneReach), and Bionet (8406.TW), positioning itself as a consumer-centric wellness leader rather than a pure-play clinical oncology provider. The company's leadership is anchored by Chairman Vincent Lin (Yung-Hsiang Lin), a prominent figure in the biotechnology sector who also serves as Chairman and General Manager of the parent group, TCI Co., Ltd. (8436.TW). Lin, an alumnus of National Chung Hsing University with a degree in Botany, is a prolific innovator holding over 600 patents and was recognized as the EY Entrepreneur of the Year for Smart Innovation. General Manager Cindy Chen oversees the firm's strategic operations and investor relations, driving the integration of genomic research with commercial health solutions. The founding vision was established by William Yang, the founder of the TCI Group, which remains a dominant stakeholder. The board is further strengthened by institutional representation from Yung-Chiang Investment and Yang Guang Investment, reflecting a governance structure deeply rooted in the broader TCI Group's R&D-heavy "Bio-Design" ecosystem.